A pilot study for universal testing and treatment of Latent Tuberculosis Infection (LTBI)

Phase 4

Completed

• Conditions: atent Tuberculosis Infection; Latent Tuberculosis Infection; Respiratory - Other respiratory disorders / diseases; Infection - Other infectious diseases

• Registration Number: ACTRN12619001439134
• Lead Sponsor: Woolcock Institute of Medical Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-10-17
• Study Completion: 2021-06-15
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 2834

Inclusion Criteria

Resident in any of three selected Aps in Ca Mau Province, Vietnam

Exclusion Criteria

Exclusion criteria for the TEST phase;
No exclusion criteria for the test phase.

Exclusion criteria for the TREAT phase;
* Pregnant women or women planning and attempting to fall pregnant
* Active TB

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of eligible patients who complete at least 80% of doses of the required treatment, via record of drug delivery (directly observed therapy)[18 weeks from treatment initiation for RIF regimen and 12 weeks from treatment initiation for 3HP regimen]